Cardio Renal Outcomes with Newer Antidiabetics

Chronic kidney disease (CKD) with type 2 diabetes (T2D) is a major public health problem, resulting in significant cardiovascular and kidney adverse outcomes worldwide. Despite the widespread use of standard-of-care therapies for CKD with T2D over the past few decades, rates of progression to end-stage kidney disease remain high. This CME talks about the Cardio Renal Outcomes with Newer Antidiabet...